Body Handbook Catalogue Profile Ranking
Healthcare BODY HANDBOOK
Healthcare ยท ยง606
Anticholinergic Burden
Half the drugs that quietly damage your memory are ones you do not file under "medication": the diphenhydramine in Benadryl, ZzzQuil, and Tylenol PM. They block acetylcholine, the brain signal Alzheimer's attacks first, and the harm adds up. Three years of daily strong use is tied to a 50% higher dementia risk in older adults Gray 2015. The fix is free: count your load, swap the worst offenders for gentler drugs, and the dry mouth and fog ease within a week.
Avoid ยท As-needed Evidence Moderate Chapter Healthcare

Acetylcholine runs your parasympathetic housekeeping and your memory circuits. Anticholinergic drugs sit on those receivers and block the signal. In the mouth that is cottonmouth, in the gut constipation, in the eye trouble focusing near. In the brain's memory hardware it is slower thinking now and structural change later 1. The dampened circuit is the one already losing cells with age, so you are taxing a system running on lower reserves.

The pattern is dose-response and it holds three ways. A little does almost nothing; about three years of daily strong use pushes dementia incidence roughly half again as high 2. It repeats across drug classes and is stronger in people diagnosed before 80 3. The cleanest test compares two bladder drugs for the same problem: the anticholinergic raised dementia risk, the beta-3 agonist did not 4.

It is not just old brains. In 40-to-71-year-olds, higher load tracked slower reasoning and weaker memory before any visible atrophy 5.

This is a one-time inventory plus a habit of checking new bottles. A community pharmacist can score it; you do not need a specialist.

The common swaps: cetirizine or loratadine for diphenhydramine; mirabegron or brain-blind trospium for oxybutynin 4; an SSRI for amitriptyline used as an antidepressant 7.

The near-term wins arrive fast; the real prize you never feel.

  • Within a week off a strong one: the mouth stops feeling like cotton, the afternoon fog lifts, reading glasses feel easier.
  • By a month: many who took Tylenol PM nightly sleep about the same without it and wake clearer. Walking confidence returns.
  • Long game: every high-burden year you skip is subtracted from the exposure category that drives the risk 2.
The fine print โ€” when to skip it, and what people get wrong
  • "Over the counter, so it's fine." Diphenhydramine scores maximum on the burden scale and sat in the high-risk group 2.
  • "My list is short." Most people undercount by half, skipping eye drops, allergy pills, and OTC combos 8.
  • Swapping strong for strong. Dropping a bladder drug but starting a tricyclic for pain just moves the load. Track the total.
  • Expecting the swap to sedate. Cetirizine treats allergy but will not put you to sleep; that sleep problem is separate.

Burden raises fall risk about a fifth 9; the 2023 Beers Criteria say avoid strong anticholinergics in older adults with a fall history 7.

References
  1. 1Risacher SL, McDonald BC, Tallman EF, West JD, Farlow MR, Unverzagt FW, Gao S, Boustani M, Crane PK, Petersen RC, Jack CR, Jagust WJ, Aisen PS, Weiner MW, Saykin AJ (2016). Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults. JAMA Neurology. link
  2. 2Gray SL, Anderson ML, Dublin S, Hanlon JT, Hubbard R, Walker R, Yu O, Crane PK, Larson EB (2015). Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Internal Medicine. link
  3. 3Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J (2019). Anticholinergic drug exposure and the risk of dementia: a nested case-control study. JAMA Internal Medicine. link
  4. 4Welk B, McArthur E (2022). Increased risk of dementia among patients with overactive bladder treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study. BJU International. link
  5. 5Mur J, Cox SR, Marioni RE, Muniz-Terrera G, Russ TC (2022). Anticholinergic burden in middle and older age is associated with lower cognitive function, but not with brain atrophy. British Journal of Clinical Pharmacology. link
  6. 6Boustani M, Campbell N, Munger S, Maidment I, Fox C (2008). Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. link
  7. 7AGS (2023). American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society. link
  8. 8Salahudeen MS, Duffull SB, Nishtala PS (2015). Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatrics. link
  9. 9Stewart C, Taylor-Rowan M, Soiza RL, Quinn TJ, Loke YK, Myint PK (2021). Anticholinergic burden measures and older people's falls risk: a systematic prognostic review. Therapeutic Advances in Drug Safety. link
ยท
606